The Pennant Group, Inc. (NASDAQ:PNTG) Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. decreased its holdings in The Pennant Group, Inc. (NASDAQ:PNTG) by 33.2% in the 4th quarter, HoldingsChannel reports. The firm owned 525,072 shares of the company’s stock after selling 260,391 shares during the quarter. Russell Investments Group Ltd.’s holdings in The Pennant Group were worth $7,309,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Boston Partners raised its position in shares of The Pennant Group by 26.0% during the 3rd quarter. Boston Partners now owns 212,897 shares of the company’s stock worth $2,369,000 after buying an additional 43,978 shares in the last quarter. Vanguard Group Inc. raised its holdings in The Pennant Group by 0.8% during the third quarter. Vanguard Group Inc. now owns 1,693,196 shares of the company’s stock worth $18,845,000 after purchasing an additional 14,138 shares in the last quarter. First Eagle Investment Management LLC lifted its position in The Pennant Group by 16.7% in the third quarter. First Eagle Investment Management LLC now owns 397,900 shares of the company’s stock worth $4,429,000 after purchasing an additional 56,893 shares during the period. Paradigm Capital Management Inc. NY boosted its stake in The Pennant Group by 79.1% during the 3rd quarter. Paradigm Capital Management Inc. NY now owns 1,196,500 shares of the company’s stock valued at $13,317,000 after purchasing an additional 528,612 shares in the last quarter. Finally, Kent Lake Capital LLC increased its position in shares of The Pennant Group by 34.6% during the 3rd quarter. Kent Lake Capital LLC now owns 583,631 shares of the company’s stock valued at $6,496,000 after purchasing an additional 150,187 shares during the period. 85.88% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on PNTG. Truist Financial raised their target price on The Pennant Group from $16.00 to $21.00 and gave the company a “hold” rating in a research note on Friday, March 1st. Stephens reissued an “overweight” rating and set a $23.00 target price on shares of The Pennant Group in a research note on Tuesday. Finally, Oppenheimer upped their price target on The Pennant Group from $18.00 to $22.00 and gave the company an “outperform” rating in a report on Friday, March 1st.

The Pennant Group Stock Performance

The Pennant Group stock opened at $20.91 on Wednesday. The Pennant Group, Inc. has a fifty-two week low of $10.31 and a fifty-two week high of $22.00. The firm’s 50 day simple moving average is $19.87 and its 200-day simple moving average is $16.18. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.12 and a quick ratio of 1.12. The company has a market cap of $627.51 million, a P/E ratio of 47.52, a price-to-earnings-growth ratio of 2.26 and a beta of 2.01.

The Pennant Group (NASDAQ:PNTG) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.01). The firm had revenue of $145.95 million for the quarter, compared to analysts’ expectations of $136.79 million. The Pennant Group had a return on equity of 12.78% and a net margin of 2.46%. During the same quarter in the previous year, the firm posted $0.15 earnings per share. As a group, equities research analysts predict that The Pennant Group, Inc. will post 0.73 EPS for the current year.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.